Story preview
At $2 a share, BioStem Technologies (BSEM) CEO exercised options for 250,000 shares.
About this story
- Published
- Oct 9, 2026, 8:30 PM UTC
Topics in this story
Continue reading on the publisher site for the full article.
Read on publisher →Stock Titan
News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee